Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania

被引:19
作者
Paulozzi, Leonard J. [1 ]
Stier, Daniel D. [2 ]
机构
[1] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA
[2] William Mitchell Coll Law, Publ Hlth Law Network, St Paul, MN USA
关键词
opioid; overdose; regulation; drug abuse; poisoning; mortality; UNITED-STATES;
D O I
10.1057/jphp.2010.27
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Drug overdose mortality nearly doubled in the United States from 1999 to 2004, with most of the increase due to prescription drug overdoses. Studying mortality rates in states that did not experience such increases may identify successful prescription overdose prevention strategies. We compared New York, a state that did not experience an overdose increase, with its neighbor, Pennsylvania. New York and Pennsylvania had prescription drug monitoring programs (PDMPs), but New York's PDMP was better funded and made use of serialized, tamperproof prescription forms. Per capita usage of the major prescription opioids in New York was two-thirds that of Pennsylvania. The drug overdose death rate in Pennsylvania was 1.6 times that of New York in 2006. Differences between New York and Pennsylvania might be due to the regulatory environment in New York State. Journal of Public Health Policy (2010) 31, 422-432. doi:10.1057/jphp.2010.27
引用
收藏
页码:422 / 432
页数:11
相关论文
共 50 条
  • [41] Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health
    Ali, Mir M.
    Dowd, William N.
    Classen, Timothy
    Mutter, Ryan
    Novak, Scott P.
    ADDICTIVE BEHAVIORS, 2017, 69 : 65 - 77
  • [42] THE "NEW" DRUG WAR
    Oliva, Jennifer D.
    El-Sabawi, Taleed
    VIRGINIA LAW REVIEW, 2024, 110 (05) : 1103 - 1168
  • [43] Preventing Opioid Misuse with Prescription Drug Monitoring Programs: A Framework for Evaluating the Success of State Public Health Laws
    Haffajee, Rebecca L.
    HASTINGS LAW JOURNAL, 2016, 67 (06) : 1621 - 1694
  • [44] Prescription drug monitoring programs in the United States of America
    Felix, Sausan El Burai
    Mack, Karin
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (04): : 270 - 276
  • [45] Impact of benzodiazepines and polysubstance status on repeat non-fatal drug overdoses
    Mayberry, Sarah
    Nechuta, Sarah
    Krishnaswami, Shanthi
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 123
  • [46] PRESCRIPTION DRUG MONITORING PROGRAMS The Role of Asymmetric Information on Drug Availability and Abuse
    Meinhofer, Angelica
    AMERICAN JOURNAL OF HEALTH ECONOMICS, 2018, 4 (04) : 504 - 526
  • [47] Prescription Drug Misuse and Arrest History
    Ford, Jason
    Wright, Lauren
    SUBSTANCE USE & MISUSE, 2017, 52 (13) : 1772 - 1777
  • [48] The evolution of prescription drug monitoring programs
    Ashburn, Michael A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (07) : 852 - 853
  • [49] Prescription Drug Abuse: Insight Into the Epidemic
    Hernandez, S. H.
    Nelson, L. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) : 307 - 317
  • [50] Prescription Drug Misuse: Sources of Controlled Medications in Adolescents
    Schepis, Ty S.
    Wilens, Timothy E.
    McCabe, Sean Esteban
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (07) : 670 - +